Skip to main content
. 2015 Mar 5;10(3):e0119494. doi: 10.1371/journal.pone.0119494

Fig 2. Proportions of men with non-metastatic cancer treated by different modalities and stratified by NICE risk group from 2000–2010.

Fig 2